Sopharma AD Company Description
Sopharma AD produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally.
The company operates through Production of Pharmaceutical Products; Distribution of Pharmaceutical Products (Goods); and Others.
It offers Carsil to treat liver disease; Tempalgin and Analgin, a painkiller; Tabex, drug used for smoking secession; Tribestan, drug used for stimulation of the male reproductive system; Broncholytin, which is used to suppress cough; Nivalin, used for diseases of the peripheral nervous system; Methylprednisolon, for severe allergies and life-threatening conditions; Vitamin C; Valeriana, used to reduce the stress; and medical devices, such as gauzes, compresses, and dressing.
The company also provides food supplements; medicinal cosmetics, including plasters, bandages, and sanitary-hygiene products focused; and prescription medicines, on the counter products, and veterinary products.
In addition, the company distributes pharmaceuticals, medical supplies, sanitary materials, vitamins, food supplements, and cosmetics; and provides contract manufacturing services; packaging services; and product development services.
Further, it is involved in trading of food supplements; secondary packaging services for pharmaceutical products and real estate leases; trades, transports, and packages radioactive materials and nuclear equipment for medicinal use, household electronics, and electrical equipment; purchases, grows, produces, and trades in herbs and medicinal plant; and provision of public opinion research services.
Additionally, the company engages in the offline and online retail trade of medicinal products and medical equipment; production of non-medicinal, and other products; and franchising, know-how, and rental of properties, as well as in trading, consulting, and other activities.
Sopharma AD was founded in 1933 and is headquartered in Sofia, Bulgaria.
Country | Bulgaria |
Founded | 1933 |
Industry | Pharmaceutical Preparations |
Employees | 4,721 |
CEO | Ognian Donev |
Contact Details
Address: 16 Iliensko shosse street Sofia, 1220 Bulgaria | |
Phone | 359 28 13 42 00 |
Website | sopharmagroup.com |
Stock Details
Ticker Symbol | SFA |
Exchange | Bulgarian Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | BGN |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Ognian Donev | Chief Executive Officer |
Boris Borisov | Chief Financial Officer |
Pelagia Viatcheva | Head of Investor Relations |